GENEVA, Switzerland (AFP) — US pharmaceutical giant Johnson & Johnson said Tuesday it plans to provide 500 million doses of its vaccine for poor countries once results of clinical trials are announced by the end of January. It plans to sell the vaccine at cost price and will provide the doses to Gavi, the Vaccine Alliance, the group’s scientific director Paul Stoffels told a virtual round table in Geneva. The vaccine is currently undergoing final-stage […]